Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors.

Halfdanarson TR, Rubin J, Farnell MB, Grant CS, Petersen GM.

Endocr Relat Cancer. 2008 Jun;15(2):409-27. doi: 10.1677/ERC-07-0221. Review.

2.

Surgical management of pancreatic endocrine tumors.

Fendrich V, Waldmann J, Bartsch DK, Langer P.

Nat Rev Clin Oncol. 2009 Jul;6(7):419-28. doi: 10.1038/nrclinonc.2009.82. Epub 2009 Jun 9. Review.

PMID:
19506584
3.

[Management of duodenal-pancreatic endocrine tumors].

Partensky C.

J Chir (Paris). 2000 Jun;137(3):142-50. Review. French.

PMID:
10915980
4.

Liver transplantation for primary or secondary endocrine tumors.

Gregoire E, Le Treut YP.

Transpl Int. 2010 Jul;23(7):704-11. doi: 10.1111/j.1432-2277.2010.01110.x. Epub 2010 May 14.

5.

Proliferative rate in endoscopic ultrasound fine-needle aspiration of pancreatic endocrine tumors: correlation with clinical behavior.

Alexiev BA, Darwin PE, Goloubeva O, Ioffe OB.

Cancer. 2009 Feb 25;117(1):40-5. doi: 10.1002/cncy.20014.

6.

Telomerase activity in pancreatic endocrine tumors.

Tang SJ, Dumot JA, Wang L, Memmesheimer C, Conwell DL, Zuccaro G, Goormastic M, Ormsby AH, Cowell J.

Am J Gastroenterol. 2002 Apr;97(4):1022-30.

PMID:
12003383
7.

Ductulo-insular pancreatic endocrine neoplasms: clinicopathologic analysis of a unique subtype of pancreatic endocrine neoplasms.

Deshpande V, Selig MK, Nielsen GP, Fernandez-del Castillo C, Lauwers GY.

Am J Surg Pathol. 2003 Apr;27(4):461-8.

PMID:
12657930
8.

Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups.

Hochwald SN, Zee S, Conlon KC, Colleoni R, Louie O, Brennan MF, Klimstra DS.

J Clin Oncol. 2002 Jun 1;20(11):2633-42.

PMID:
12039924
9.

Surgical treatment of pancreatic endocrine neoplasms.

Gomez-Rivera F, Stewart AE, Arnoletti JP, Vickers S, Bland KI, Heslin MJ.

Am J Surg. 2007 Apr;193(4):460-5.

PMID:
17368289
10.

[Treatment of pancreatic-duodenal endocrine tumors].

O'Toole D, Kianmanesh R, Farges O, Ruszniewski P.

Rev Prat. 2002 Sep 15;52(14):1546-53. Review. French.

PMID:
12412302
11.

[Endocrine tumors of the pancreas: classification, clinical and molecular prognostic factors].

Terris B.

Ann Pathol. 2002 Oct;22(5):367-74. Review. French.

PMID:
12483154
12.

Survival from malignant digestive endocrine tumors in England and Wales: a population-based study.

Lepage C, Rachet B, Coleman MP.

Gastroenterology. 2007 Mar;132(3):899-904. Epub 2007 Jan 5.

PMID:
17383419
13.

Treatment of endocrine pancreatic tumors.

Fjällskog ML, Janson ET.

Acta Oncol. 2005;44(4):329-38. Review.

PMID:
16120541
14.

[Natural history and prognosis of pancreatic endocrine tumors].

Ruszniewski P, Terris B.

Gastroenterol Clin Biol. 2003 Mar;27(3 Suppl):S20-5. Review. French. No abstract available.

15.

Surgical therapy for endocrine tumors of abdominal origin.

Sloan DA, Schwartz RW, Kenady DE.

Curr Opin Oncol. 1993 Jan;5(1):100-9. Review.

PMID:
8427883
16.

Concomitant pancreatic endocrine neoplasm and intraductal papillary mucinous neoplasm: a case report and literature review.

Kadota Y, Shinoda M, Tanabe M, Tsujikawa H, Ueno A, Masugi Y, Oshima G, Nishiyama R, Tanaka M, Mihara K, Abe Y, Yagi H, Kitago M, Itano O, Kawachi S, Aiura K, Tanimoto A, Sakamaoto M, Kitagawa Y.

World J Surg Oncol. 2013 Mar 21;11:75. doi: 10.1186/1477-7819-11-75. Review.

17.

Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.

Gonçalves TD, Toledo RA, Sekiya T, Matuguma SE, Maluf Filho F, Rocha MS, Siqueira SA, Glezer A, Bronstein MD, Pereira MA, Jureidini R, Bacchella T, Machado MC, Toledo SP, Lourenço DM Jr.

J Clin Endocrinol Metab. 2014 Jan;99(1):E89-96. doi: 10.1210/jc.2013-1768. Epub 2013 Dec 20.

PMID:
24178797
18.

[Gastroenteropancreatic endocrine tumors: prognostic factors].

Bordi C.

Pathologica. 2003 Oct;95(5):248-50. Italian. No abstract available.

PMID:
14988998
19.

An immunohistochemical study of cyclooxygenase (COX)-2 expression in endocrine tumors of the pancreas.

Okami J, Nakamori S, Yamamoto H, Sakon M, Tsujie M, Hayashi N, Nagano H, Dono K, Umeshita K, Ishikawa O, Ohigashi H, Monden M.

J Exp Clin Cancer Res. 2002 Dec;21(4):569-76.

PMID:
12636104
20.

An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors.

Fendrich V, Langer P, Celik I, Bartsch DK, Zielke A, Ramaswamy A, Rothmund M.

Ann Surg. 2006 Dec;244(6):845-51; discussion 852-3.

Supplemental Content

Support Center